MicroPort's Firebird 2 Stent Showed up in TCT2007

At Beijing time 9:30 pm on October 22, the much-expected televised TCT2007 Fuwai surgery was conducted in Fuwai Hospital Interventional Catheter Room. This broadcast includes three operations, and MicroPort's self-developed FireBird 2 stent was applied in the first operation. This first case was broadcast live to the whole world, and conducted by Academician Gao Runlin, praised by TCT Chairman Martin B. Leon as "father of China's cardiovascular interventional therapy". The whole surgery broadcast, under the coordination of General Secretary Xu Bo, went quite smoothly and amazingly, and the surgery won unanimous applause from leading experts both home and abroad. Present at Fuwai Hospital operation scene were Wang Li, MicroPort's Chief Marketing Officer, Xu Yimin, Vice President in charge of quality, clinical issues and registration and Tang Zhirong, Director of Research Center DES (drug-eluting stent) Project, while MicroPort CTO Luo Qiyi at US TCT conference also felt the encouraging moment.